Gene therapy: Industrial strength

Eric Bender
Additional contact information
Eric Bender: Eric Bender is a freelance science writer based in Newton, Massachusetts.

Nature, 2016, vol. 537, issue 7619, S57-S59

Abstract: After a series of setbacks, genetic therapies are finally moving beyond small academic trials towards approval as treatments.

Date: 2016
References: Add references at CitEc
Citations:

Downloads: (external link)
https://www.nature.com/articles/537S57a Abstract (text/html)
Access to the full text of the articles in this series is restricted.

Related works:
This item may be available elsewhere in EconPapers: Search for items with the same title.

Export reference: BibTeX RIS (EndNote, ProCite, RefMan) HTML/Text

Persistent link: https://EconPapers.repec.org/RePEc:nat:nature:v:537:y:2016:i:7619:d:10.1038_537s57a

Ordering information: This journal article can be ordered from
https://www.nature.com/

DOI: 10.1038/537S57a

Access Statistics for this article

Nature is currently edited by Magdalena Skipper

More articles in Nature from Nature
Bibliographic data for series maintained by Sonal Shukla () and Springer Nature Abstracting and Indexing ().